Medicines for older people: assessment and transparency at the European Medicines Agency regarding cardiovascular and antithrombotic medicinal products

被引：0
|
作者：
Francesca Cerreta
Andreia Padrão
Izabela Skibicka-Stepien
Anna Strampelli
Maria Silvia de Orbe Izquierdo
机构：
[1] European Medicines Agency,
[2] Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS),undefined
[3] Mylan,undefined
来源：
European Geriatric Medicine | 2018年 / 9卷
关键词：
Older people; European Medicines Agency; Marketing authorization; Pharmacovigilance; Transparency;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：415 / 418
页数：3
相关论文
共 50 条
  • [1] Medicines for older people: assessment and transparency at the European Medicines Agency regarding cardiovascular and antithrombotic medicinal products
    Cerreta, Francesca
    Padrao, Andreia
    Skibicka-Stepien, Izabela
    Strampelli, Anna
    de Orbe Izquierdo, Maria Silvia
    [J]. EUROPEAN GERIATRIC MEDICINE, 2018, 9 (04) : 415 - 418
  • [2] Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products
    A. Ceci
    M. Felisi
    M. Catapano
    P. Baiardi
    L. Cipollina
    S. Ravera
    S. Bagnulo
    S. Reggio
    G. Rondini
    [J]. European Journal of Clinical Pharmacology, 2002, 58 : 495 - 500
  • [3] Medicines for children licensed by the European agency for the evaluation of medicinal products
    Ceci, A
    Felisi, M
    Catapano, M
    Baiardi, P
    Cipollina, L
    Ravera, S
    Bagnulo, S
    Reggio, S
    Rondini, G
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (08) : 495 - 500
  • [4] A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola
    Cavaleri, Marco
    Thomson, Andrew
    Salmonson, Tomas
    Hemmings, Robert J.
    [J]. CLINICAL TRIALS, 2016, 13 (01) : 101 - 104
  • [5] Readability Assessment of Package Inserts of Biological Medicinal Products from the European Medicines Agency Website
    Angeles Pinero-Lopez, Ma
    Modamio, Pilar
    Lastra, Cecilia F.
    Marino, Eduardo L.
    [J]. DRUG SAFETY, 2014, 37 (07) : 543 - 554
  • [6] Readability Assessment of Package Inserts of Biological Medicinal Products from the European Medicines Agency Website
    Mª. Ángeles Piñero-López
    Pilar Modamio
    Cecilia F. Lastra
    Eduardo L. Mariño
    [J]. Drug Safety, 2014, 37 : 543 - 554
  • [7] Regulating medicines in Europe: the European Medicines Agency, marketing authorisation, transparency and pharmacovigilance
    Permanand, G
    Mossialos, E
    McKee, M
    [J]. CLINICAL MEDICINE, 2006, 6 (01) : 87 - 90
  • [8] European Medicines Agency-more transparency needed
    不详
    [J]. LANCET, 2010, 375 (9728): : 1753 - 1753
  • [9] Medicines transparency at the European Medicines Agency (EMA) in the new information age: the perspectives of patients
    Way, Dominic
    Bouder, Frederic
    Loefstedt, Ragnar
    Evensen, Darrick
    [J]. JOURNAL OF RISK RESEARCH, 2016, 19 (09) : 1185 - 1215
  • [10] Biomarker and Companion Diagnostics-A Review of Medicinal Products Approved by the European Medicines Agency
    Orellana Garcia, Laura Patricia
    Ehmann, Falk
    Hines, Philip A.
    Ritzhaupt, Armin
    Brand, Angela
    [J]. FRONTIERS IN MEDICINE, 2021, 8
12345